NCT03479151 Magnetic Resonance Guided High Intensity Focused Ultrasound (MRgHIFU) for Pain Palliation of Bone Metastases Status WITHDRAWN Phase NA
NCT03466034 The Role of Hypoxia as a Selective Pressure for TP53 Mutations Status TERMINATED Phase N/A
NCT03432429 Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study Status COMPLETED Phase N/A
NCT03424668 The European Prospective Investigation Into Cancer in Norfolk Prospective Population Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03415854 Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD) Status COMPLETED Phase PHASE2
NCT03410030 Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) Status COMPLETED Phase PHASE1/PHASE2
NCT03371485 AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT03328247 Achieving Self-directed Integrated Cancer Aftercare (ASICA) in Melanoma Status COMPLETED Phase NA
NCT03307746 A Combination of Rituximab and Varlilumab Immunotherapy in Patients with B-cell Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT03294434 Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study) Status COMPLETED Phase N/A
NCT03245177 Pembrolizumab in Combination With Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Status WITHDRAWN Phase PHASE1
NCT03150576 Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer Status RECRUITING Phase PHASE2/PHASE3
NCT03117920 A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT03103152 A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer Progression Status COMPLETED Phase PHASE2/PHASE3
NCT03096093 Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03028766 WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer Status COMPLETED Phase PHASE1